<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Faculty papers</title>
<copyright>Copyright (c) 2013 Thomas Jefferson University All rights reserved.</copyright>
<link>http://jdc.jefferson.edu/medgenfp</link>
<description>Recent documents in Faculty papers</description>
<language>en-us</language>
<lastBuildDate>Fri, 22 Feb 2013 17:13:12 PST</lastBuildDate>
<ttl>3600</ttl>








<item>
<title>Diverticular and aneurysmal structures of the left ventricle in adults: report of a case within the context of a literature review.</title>
<link>http://jdc.jefferson.edu/medgenfp/3</link>
<guid isPermaLink="true">http://jdc.jefferson.edu/medgenfp/3</guid>
<pubDate>Fri, 03 Aug 2012 12:32:41 PDT</pubDate>
<description>
	<![CDATA[
	<p>Left ventricular outpouchings are increasingly detected on cardiovascular imaging. Herein, we describe the case of a 45-year-old man who underwent noncardiac preoperative imaging and was found to have an asymptomatic left ventricular outpouching. The patient underwent successful surgical repair of the structure. When left ventricular outpouchings are detected, the main differential diagnoses are pseudoaneurysm, aneurysm, and diverticulum. The outcomes for these conditions differ substantially, and accurate diagnosis can be crucial in making clinical decisions. We review the relevant medical literature, outline the natural history of these left ventricular abnormalities, and discuss options in regard to their management.</p>

	]]>
</description>

<author>Premraj Makkuni et al.</author>


<category>Asymptomatic Diseases</category>

<category>Cardiac Surgical Procedures</category>

<category>Diagnosis, Differential</category>

<category>Diverticulum</category>

<category>Heart Aneurysm</category>

<category>Heart Diseases</category>

<category>Heart Ventricles</category>

<category>Humans</category>

<category>Incidental Findings</category>

<category>Male</category>

<category>Middle Aged</category>

<category>Radionuclide Ventriculography</category>

<category>Tomography, Emission-Computed, Single-Photon</category>

<category>Tomography, X-Ray Computed</category>

<category>Treatment Outcome</category>

<category>Ultrasonography, Doppler, Color</category>

</item>






<item>
<title>Embolic complication of Tako-Tsubo cardiomyopathy.</title>
<link>http://jdc.jefferson.edu/medgenfp/2</link>
<guid isPermaLink="true">http://jdc.jefferson.edu/medgenfp/2</guid>
<pubDate>Fri, 03 Aug 2012 12:24:01 PDT</pubDate>
<description>
	<![CDATA[
	
	]]>
</description>

<author>Vincent M. Figueredo et al.</author>


<category>Aged, 80 and over</category>

<category>Amputation</category>

<category>Anemia</category>

<category>Dyspnea</category>

<category>Electrocardiography</category>

<category>Female</category>

<category>Humans</category>

<category>Leg</category>

<category>Popliteal Artery</category>

<category>Takotsubo Cardiomyopathy</category>

<category>Thromboembolism</category>

<category>Tibial Arteries</category>

</item>






<item>
<title>Dronedarone.</title>
<link>http://jdc.jefferson.edu/medgenfp/1</link>
<guid isPermaLink="true">http://jdc.jefferson.edu/medgenfp/1</guid>
<pubDate>Tue, 20 Mar 2012 09:15:56 PDT</pubDate>
<description>
	<![CDATA[
	<p>Amiodarone is the most effective antiarrhythmic drug for maintaining sinus rhythm for patients with atrial fibrillation. Extra-cardiac side effects have been a limiting factor, especially during chronic use, and may offset its benefits. Dronedarone is a noniodinated benzofuran derivative of amiodarone that has been developed for the treatment of atrial fibrillation and atrial flutter. Similar to amiodarone, dronedarone is a potent blocker of multiple ion currents, including the rapidly activating delayed-rectifier potassium current, the slowly activating delayed-rectifier potassium current, the inward rectifier potassium current, the acetylcholine activated potassium current, peak sodium current, and L-type calcium current, and exhibits antiadrenergic effects. It has been studied for maintenance of sinus rhythm and control of ventricular response during episodes of atrial fibrillation. Dronedarone reduces mortality and morbidity in patients with high-risk atrial fibrillation, but may be unsafe in those with severe heart failure. This article will review evidence of safety and effectiveness of dronedarone in patients with atrial fibrillation.</p>

	]]>
</description>

<author>Chinmay Patel et al.</author>


<category>Amiodarone</category>

<category>Anti-Arrhythmia Agents</category>

<category>Atrial Fibrillation</category>

<category>Atrial Flutter</category>

<category>Humans</category>

<category>Ion Channels</category>

<category>Kaplan-Meier Estimate</category>

</item>





</channel>
</rss>
